Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Provectus Reports Further Positive Phase 2 Data On PV-10 For Metastatic Melanoma At A
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2170029" data-attributes="member: 124445"><p>Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR. These data were included in Abstract #8534, entitled "Chemoablation of metastatic melanoma with rose bengal (PV-10)", to be presented by Dr... <a href="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/zVKNsrq_rgE" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/zVKNsrq_rgE/3D25" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2170029, member: 124445"] Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR. These data were included in Abstract #8534, entitled "Chemoablation of metastatic melanoma with rose bengal (PV-10)", to be presented by Dr... [URL="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/0/da"][IMG]http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/1/da"][IMG]http://feedads.g.doubleclick.net/~a/Y59a5N6a1-sQBu7nYbNbgpo9pTo/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/zVKNsrq_rgE[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/zVKNsrq_rgE/3D25]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top